Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

PURPOSE: Patients with myelodysplastic syndrome (MDS) are at risk of relapse after allogeneic hematopoietic cell transplantation. The utility of ultra-deep genomic testing to predict and the impact of conditioning intensity to prevent MDS relapse are unknown. METHODS: Targeted error-corrected DNA se...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillon, Laura W., Gui, Gege, Logan, Brent R., Fei, Mingwei, Ghannam, Jack, Li, Yuesheng, Licon, Abel, Alyea, Edwin P., Bashey, Asad, Devine, Steven M., Fernandez, Hugo F., Giralt, Sergio, Hamadani, Mehdi, Howard, Alan, Maziarz, Richard T., Porter, David L., Warlick, Erica D., Pasquini, Marcelo C., Scott, Bart L., Horwitz, Mitchell E., Deeg, H. Joachim, Hourigan, Christopher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140814/
https://www.ncbi.nlm.nih.gov/pubmed/34036237
http://dx.doi.org/10.1200/PO.20.00355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140814/
https://www.ncbi.nlm.nih.gov/pubmed/34036237
http://dx.doi.org/10.1200/PO.20.00355

Ejemplares similares